PULM
PULM
NASDAQ · Pharmaceuticals

Pulmatrix Inc

$2.49
+0.34 (+15.81%)
As of Mar 22, 10:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
8.11M
Net Income
-9,930,353
Gross Margin
Profit Margin
-122.5%
Rev Growth
+14.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.2% 38.2%
Operating Margin -125.1% -112.6% 38.9% 37.8%
Profit Margin -122.5% -116.3% 28.2% 29.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 8.11M 7.07M 1.27M 1.06M
Gross Profit 483.8K 404.8K
Operating Income -10,142,145 -7,956,703 492.2K 400.8K
Net Income -9,930,353 -7,790,548 357.5K 314.0K
Gross Margin 38.2% 38.2%
Operating Margin -125.1% -112.6% 38.9% 37.8%
Profit Margin -122.5% -116.3% 28.2% 29.6%
Rev Growth +14.7% +14.7% -7.0% +4.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.67M 4.18M
Total Equity 5.19M 5.68M
D/E Ratio 0.71 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,235,780 -8,476,282 531.9K 486.7K
Free Cash Flow 275.9K 324.6K